Cargando…

Prevalence of antibodies against SARS‐CoV‐2 in the Norwegian population, August 2021

BACKGROUND: One year into the COVID‐19 pandemic, the cumulative number of confirmed COVID‐19 cases in Norway was still low. In January 2021, when the Norwegian COVID‐19 vaccination campaign started, the national seroprevalence estimate of SARS‐CoV‐2 antibodies was 3.2%. We have conducted a nationwid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tunheim, Gro, Rø, Gunnar Øyvind Isaksson, Chopra, Adity, Aase, Audun, Kran, Anne‐Marte Bakken, Vaage, John Torgils, Lund‐Johansen, Fridtjof, Hungnes, Olav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349429/ https://www.ncbi.nlm.nih.gov/pubmed/35770841 http://dx.doi.org/10.1111/irv.13024

Ejemplares similares

Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic
por: Tunheim, Gro, et al.
Publicado: (2021)

Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
por: König, Marton, et al.
Publicado: (2022)

Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study
por: Laake, Ida, et al.
Publicado: (2018)

The burden of hospital-attended influenza in Norwegian children
por: Bøås, Håkon, et al.
Publicado: (2022)

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023)

T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
por: Wolf, Asia-Sophia, et al.
Publicado: (2023)

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
por: Kared, Hassen, et al.
Publicado: (2022)

Detection of anti‐NS1 antibodies after pandemic influenza exposure: Evaluation of a serological method for distinguishing H1N1pdm09 infected from vaccinated cases
por: Robertson, Anna Hayman, et al.
Publicado: (2020)

Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort
por: Landaas, Elisabeth Toverud, et al.
Publicado: (2021)

Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
por: Jorgensen, Kristin, et al.
Publicado: (2022)

Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine
por: Watle, Sara Viksmoen, et al.
Publicado: (2021)

Rituximab‐treated patients with lymphoma develop strong CD8 T‐cell responses following COVID‐19 vaccination
por: Riise, Jon, et al.
Publicado: (2022)

Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self‐reported severity and duration of illness
por: Tunheim, Gro, et al.
Publicado: (2019)

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
por: König, Marton, et al.
Publicado: (2023)

Molecular Epidemiology of the Norwegian SARS-CoV-2 Delta Lineage AY.63
por: Moen, Line Victoria, et al.
Publicado: (2022)

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
por: Seppälä, Elina, et al.
Publicado: (2021)

High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014
por: Bragstad, Karoline, et al.
Publicado: (2015)

Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21
por: Anda, Erik Eik, et al.
Publicado: (2022)

Indexing Quit-Smoking Interest among Norwegian Smokers 2019-2021
por: Sæbø, Gunnar, et al.
Publicado: (2023)

Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021
por: Winje, Brita Askeland, et al.
Publicado: (2021)

Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020
por: Brandal, Lin T, et al.
Publicado: (2021)

Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort study
por: Gunnes, Nina, et al.
Publicado: (2020)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2023)

Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study
por: Hovd, Markus, et al.
Publicado: (2023)

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
por: Tran, Trung The, et al.
Publicado: (2022)

Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
por: Tran, Trung The, et al.
Publicado: (2023)

A strong case for third-party testing
por: Lund-Johansen, Fridtjof
Publicado: (2023)

Counselling for burnout in Norwegian doctors: one year cohort study
por: Rø, Karin E Isaksson, et al.
Publicado: (2008)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
por: Søraas, Arne, et al.
Publicado: (2022)

E-learning course for Norwegian caregivers
por: Trae, Gro
Publicado: (2014)

Meningococcal carriage in Norwegian teenagers: strain characterisation and assessment of risk factors
por: Watle, S. V., et al.
Publicado: (2020)

Genotypic characterization of gentamicin and cephalosporin resistant Escherichia coli isolates from blood cultures in a Norwegian university hospital 2011–2015
por: Fladberg, Øyvind Andreas, et al.
Publicado: (2017)

Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients—Should We Keep Vaccinating?
por: Åsberg, Anders, et al.
Publicado: (2023)

To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study
por: Quist-Paulsen, Else, et al.
Publicado: (2019)

Do you recommend cancer screening to your patients? A cross-sectional study of Norwegian doctors
por: Bringedal, Berit, et al.
Publicado: (2019)

Norwegian nursing and medical students’ perception of interprofessional teamwork: a qualitative study
por: Aase, Ingunn, et al.
Publicado: (2014)

Why the Norwegian 2021 guideline for basic life support are different
por: Bjørshol, Conrad Arnfinn, et al.
Publicado: (2023)

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
por: Bjørlykke, Kristin H, et al.
Publicado: (2023)

Household Transmission of SARS-CoV-2: A Prospective Longitudinal Study Showing Higher Viral Load and Increased Transmissibility of the Alpha Variant Compared to Previous Strains
por: Julin, Cathinka Halle, et al.
Publicado: (2021)

Reference data set for a Norwegian medium voltage power distribution system
por: Sperstad, Iver Bakken, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oho88hg1mcc64j30togpudpd9v